Psychosocial Needs Remain Largely Unmet for Patients with Lung Cancer, Caregivers

Studies Question Further Modification of pTNM Staging as 9th Edition Deadline Approaches

Rare NUT Carcinoma Gaining Recognition in Lung Cancer Community

Assay that Combines Clinical, Radiomic Characteristics with CT Information Shown to Better Distinguish Malignant Early Lung Nodules

Adoption of VATS Continues to Vary Globally

The IASLC Supports International Day for Clean Air for Blue Skies “Healthy Air, Healthy Planet” Campaign

Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC

VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC

High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC

Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC

IMpower010: Adjuvant Atezolizumab Improved DFS in PD-L1 Expressing Stage II-IIIA NSCLC

Screening for the Biggest Cancer Killer: Beating Lung Cancer Through Screening Guidelines?